Law360, New York (August 8, 2006, 12:00 AM EDT) -- German drug maker Altana Pharma AG and its U.S. partner, Wyeth Pharmaceuticals, expanded a long-running legal campaign Tuesday with another patent infringement lawsuit over their multi-billion dollar heartburn drug Protonix.
The companies filed the lawsuit against would-be manufacturers of generic Protoxin, including Germany-based Shwarz Pharma AG and a slew of its international subsidiaries, such as Delaware-based Kremers Urban Development Co.
The lawsuit was filed Aug. 4 in the U.S. District Court for the District of New Jersey.
The lawsuit involves a generic patent challenge for a...
Altana And Wyeth Strike Again Over Protonix
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login
